Literature DB >> 3677815

Severe precocious emphysema in intravenous methylphenidate (Ritalin) abusers.

C B Sherman1, L D Hudson, D J Pierson.   

Abstract

Intravenous (IV) drug abuse is known to cause pulmonary tale granulomatosis. Reports have documented a syndrome of pulmonary vascular sclerosis in long-term IV methylphenidate users. Although this would be expected to produce restrictive lung disease, we hereby report six patients who have severe obstructive lung disease. All had used IV methylphenidate for at least four years. One of these patients died of progressive respiratory insufficiency and the others are clinically disabled. Their symptoms and airflow obstruction are more severe than those of most patients with chronic obstructive pulmonary disease. In these individuals, we cannot say that precocious obstructive lung disease is not due to a combination of smoking and other factors, nor can we be certain that methylphenidate is the offending agent. However, this cluster of cases among methylphenidate abusers suggests that long-term IV exposure to this drug might lead to early severe obstructive lung disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3677815     DOI: 10.1378/chest.92.6.1085

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

Review 1.  Pulmonary complications of intravenous drug misuse. 1. Epidemiology and non-infective complications.

Authors:  C R Hind
Journal:  Thorax       Date:  1990-11       Impact factor: 9.139

2.  A case of recurrent pneumothorax related to oral methylphenidate.

Authors:  Viboon Boonsarngsuk; Thitiporn Suwatanapongched
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

Review 3.  Respiratory toxicities from stimulant use.

Authors:  T E Albertson; W F Walby
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

4.  Sensitized nucleus accumbens dopamine terminal responses to methylphenidate and dopamine transporter releasers after intermittent-access self-administration.

Authors:  Erin S Calipari; Sara R Jones
Journal:  Neuropharmacology       Date:  2014-03-13       Impact factor: 5.250

5.  Methylphenidate and cocaine self-administration produce distinct dopamine terminal alterations.

Authors:  Erin S Calipari; Mark J Ferris; James R Melchior; Kristel Bermejo; Ali Salahpour; David C S Roberts; Sara R Jones
Journal:  Addict Biol       Date:  2012-03-28       Impact factor: 4.280

6.  Cross sectional analysis of respiratory symptoms in an injection drug user cohort: the impact of obstructive lung disease and HIV.

Authors:  M Bradley Drummond; Gregory D Kirk; Erin P Ricketts; Meredith C McCormack; J Christian Hague; John F McDyer; Shruti H Mehta; Eric A Engels; Robert A Wise; Christian A Merlo
Journal:  BMC Pulm Med       Date:  2010-05-11       Impact factor: 3.317

Review 7.  Incidence and risk of lung cancer in HIV-infected patients.

Authors:  Wenli Hou; Jun Fu; Yuanyuan Ge; Jian Du; Shucheng Hua
Journal:  J Cancer Res Clin Oncol       Date:  2013-07-28       Impact factor: 4.553

8.  Prevalence and risk factors for unrecognized obstructive lung disease among urban drug users.

Authors:  M Bradley Drummond; Gregory D Kirk; Jacquie Astemborski; Meredith C McCormack; Mariah M Marshall; Shruti H Mehta; Robert A Wise; Christian A Merlo
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-01-19

Review 9.  Interactions between HIV infection and chronic obstructive pulmonary disease: Clinical and epidemiological aspects.

Authors:  Christine Raynaud; Nicolas Roche; Christos Chouaid
Journal:  Respir Res       Date:  2011-09-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.